{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:22:14Z","timestamp":1791912134175,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Koeki Zaidan Hojin Daiwa Shoken Zaidan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005951","name":"Honjo International Scholarship Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015639","name":"Japan Cardiovascular Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008670","name":"Terumo Foundation for Life Sciences and Arts","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2026.e00849","type":"journal-article","created":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:49:01Z","timestamp":1770295741000},"page":"e00849","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Revisiting elevated HDL cholesterol, cerebral hemodynamic improvement in asymptomatic carotid artery disease: A longitudinal 15O-Gas PET study"],"prefix":"10.1016","volume":"23","author":[{"given":"Yorito","family":"Hattori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Kakino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Nakaoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soshiro","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehiro","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.neurot.2026.e00849_bib1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.neurot.2026.e00849_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5888\/pcd18.200278","article-title":"Dose-response association between high-density lipoprotein cholesterol and stroke: a systematic review and meta-analysis of prospective cohort studies","volume":"18","author":"Qie","year":"2021","journal-title":"Prev Chronic Dis"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00849_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/2047487318820976","article-title":"Increasing high-density lipoprotein cholesterol levels for cardiovascular benefit: the end of a dream?","volume":"26","author":"Pirillo","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.neurot.2026.e00849_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101642","article-title":"Angiogenic and antiangiogenic mechanisms of high density lipoprotein from healthy subjects and coronary artery diseases patients","volume":"36","author":"Li","year":"2020","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10456-018-9603-z","article-title":"High-density lipoprotein (HDL) promotes angiogenesis via S1P3-dependent VEGFR2 activation","volume":"21","author":"Jin","year":"2018","journal-title":"Angiogenesis"},{"issue":"15","key":"10.1016\/j.neurot.2026.e00849_bib6","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.1074\/jbc.275.15.11278","article-title":"High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae","volume":"275","author":"Uittenbogaard","year":"2000","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00849_bib7","first-page":"CD013573","article-title":"Pharmacological interventions for asymptomatic carotid stenosis","volume":"8","author":"Clezar","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib8","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1177\/23969873211012121","article-title":"European stroke organisation guideline on endarterectomy and stenting for carotid artery stenosis","volume":"6","author":"Bonati","year":"2021","journal-title":"Eur Stroke J"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00849_bib9","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jvs.2020.10.063","article-title":"Asymptomatic carotid artery stenosis is associated with cerebral hypoperfusion","volume":"73","author":"Khan","year":"2021","journal-title":"J Vasc Surg"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00849_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jvs.2005.02.044","article-title":"Sensitivity and specificity of color duplex ultrasound measurement in the estimation of internal carotid artery stenosis: a systematic review and meta-analysis","volume":"41","author":"Jahromi","year":"2005","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib11","first-page":"413","article-title":"Diagnosis of internal carotid artery stenosis greater than 70% with power Doppler duplex sonography","volume":"22","author":"Koga","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1053\/jscd.2001.24657","article-title":"Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarction","volume":"10","author":"Mochizuki","year":"2001","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib13","doi-asserted-by":"crossref","first-page":"fcaa020","DOI":"10.1093\/braincomms\/fcaa020","article-title":"Tadalafil may improve cerebral perfusion in small-vessel occlusion stroke-a pilot study","volume":"2","author":"\u00d6lmestig","year":"2020","journal-title":"Brain Commun"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00849_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.CIR.0000020190.45892.75","article-title":"AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases","volume":"106","author":"Pearson","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00849_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J Atherosclerosis Thromb"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40658-018-0236-5","article-title":"System evaluation of automated production and inhalation of 15 O-labeled gaseous radiopharmaceuticals for the rapid 15 O-oxygen PET examinations","volume":"5","author":"Iguchi","year":"2018","journal-title":"EJNMMI Phys"},{"issue":"9","key":"10.1016\/j.neurot.2026.e00849_bib17","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.jcbfm.9600118","article-title":"Rapid quantitative measurement of CMRO2 and CBF by dual administration of 15O-labeled oxygen and water during a single PET scan - a validation study and error analysis in anesthetized monkeys","volume":"25","author":"Kudomi","year":"2005","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib18","first-page":"177","article-title":"Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography","volume":"25","author":"Mintun","year":"1984","journal-title":"J Nucl Med"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00849_bib19","first-page":"416","article-title":"Brain oxygen utilization measured with Oxygen-15 radiotracers and positron emission tomography: generation of metabolic images","volume":"26","author":"Herscovitch","year":"1985","journal-title":"J Nucl Med"},{"issue":"I","key":"10.1016\/j.neurot.2026.e00849_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1109\/TNS.2002.807869","article-title":"Development of a GSO detector assembly for a continuous blood sampling system","volume":"50","author":"Kudomi","year":"2003","journal-title":"IEEE Trans Nucl Sci"},{"issue":"8","key":"10.1016\/j.neurot.2026.e00849_bib21","first-page":"1333","article-title":"Modeling approach to eliminate the need to separate arterial plasma in oxygen-15 inhalation positron emission tomography","volume":"34","author":"Iida","year":"1993","journal-title":"J Nucl Med"},{"issue":"18","key":"10.1016\/j.neurot.2026.e00849_bib22","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1088\/0031-9155\/59\/18\/5593","article-title":"Validity of using a 3-dimensional PET scanner during inhalation of 15O-labeled oxygen for quantitative assessment of regional metabolic rate of oxygen in man","volume":"59","author":"Hori","year":"2014","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.5853\/jos.2023.02733","article-title":"Long-term resveratrol intake for cognitive and cerebral blood flow impairment in carotid artery stenosis\/occlusion","volume":"26","author":"Hattori","year":"2024","journal-title":"J Stroke"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00849_bib24","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1161\/STROKEAHA.124.047160","article-title":"Blood midregional proadrenomedullin as a hemodynamic severity marker in asymptomatic carotid artery stenosis\/occlusion","volume":"55","author":"Hattori","year":"2024","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00849_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/01.STR.0000157667.06542.b7","article-title":"Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-lind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis","volume":"36","author":"Kwon","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neurot.2026.e00849_bib26","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000004913","article-title":"Sex differences in cerebrovascular pathologies on FLAIR in cognitively unimpaired elderly","volume":"90","author":"Fatemi","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurot.2026.e00849_bib27","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1161\/STR.0000000000000116","article-title":"Prevention of stroke in patients with silent cerebrovascular disease: a scientific statement for healthcare professionals from the American heart Association\/American stroke Association","volume":"48","author":"Smith","year":"2017","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.neurot.2026.e00849_bib28","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamacardio.2022.0912","article-title":"Association between high-density lipoprotein cholesterol levels and adverse cardiovascular outcomes in high-risk populations","volume":"7","author":"Liu","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"10","key":"10.1016\/j.neurot.2026.e00849_bib29","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1161\/HYPERTENSIONAHA.122.19912","article-title":"High HDL (High-Density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients","volume":"79","author":"Trimarco","year":"2022","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.neurot.2026.e00849_bib30","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jacl.2018.01.014","article-title":"Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: the EPOCH\u2013JAPAN study","volume":"12","author":"Hirata","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib31","first-page":"19","article-title":"Accuracy of non-invasive arterial input functions and error in quantitative images in the cerebellar reference method","volume":"58","author":"Hayashi","year":"2021","journal-title":"Kaku Igaku"},{"issue":"5","key":"10.1016\/j.neurot.2026.e00849_bib32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3174\/ajnr.A3799","article-title":"Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET","volume":"35","author":"Goetti","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"10.1016\/j.neurot.2026.e00849_bib33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3174\/ajnr.A5068","article-title":"Noninvasive evaluation of CBF and perfusion delay of Moyamoya disease using arterial spin-labeling MRI with multiple postlabeling delays: Comparison with 15O-Gas PET and DSC-MRI","volume":"38","author":"Hara","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3233\/JAD-142874","article-title":"Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease","volume":"44","author":"Wischik","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib35","first-page":"CD010632","article-title":"18F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)","volume":"1","author":"Smailagic","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.neurot.2026.e00849_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13139-019-00633-7","article-title":"Basal and acetazolamide brain perfusion SPECT in internal carotid artery stenosis","volume":"54","author":"Wong","year":"2020","journal-title":"Nucl Med Mol Imaging"},{"issue":"6","key":"10.1016\/j.neurot.2026.e00849_bib37","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/neuros\/nyy234","article-title":"Two-year clinical, cerebral hemodynamic, and cognitive outcomes of adult patients undergoing medication alone for symptomatically ischemic Moyamoya disease without cerebral misery perfusion: a prospective cohort study","volume":"84","author":"Miyoshi","year":"2019","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.neurot.2026.e00849_bib38","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/0271678X17727385","article-title":"Long-term hemodynamic changes and blood pressure in atherosclerotic major cerebral artery disease","volume":"39","author":"Yamauchi","year":"2019","journal-title":"J Cerebr Blood Flow Metabol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:01:52Z","timestamp":1777622512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S187874792600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00849","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting elevated HDL cholesterol, cerebral hemodynamic improvement in asymptomatic carotid artery disease: A longitudinal 15O-Gas PET study","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2026.e00849","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00849"}}